Page last updated: 2024-08-26

bosentan anhydrous and Morbid Obesity

bosentan anhydrous has been researched along with Morbid Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mathier, MA	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Morbid Obesity

Article	Year
Dramatic functional improvement following bariatric surgery in a patient with pulmonary arterial hypertension and morbid obesity. Chest, 2008, Volume: 134, Issue:3 Topics: Antihypertensive Agents; Bariatric Surgery; Bosentan; Continuous Positive Airway Pressure; Humans; Hypertension, Pulmonary; Lung; Male; Obesity, Morbid; Oxygen Inhalation Therapy; Sleep Apnea Syndromes; Sulfonamides; Treatment Outcome	2008

Article

Year

Dramatic functional improvement following bariatric surgery in a patient with pulmonary arterial hypertension and morbid obesity.

Chest, 2008, Volume: 134, Issue:3

Topics: Antihypertensive Agents; Bariatric Surgery; Bosentan; Continuous Positive Airway Pressure; Humans; Hypertension, Pulmonary; Lung; Male; Obesity, Morbid; Oxygen Inhalation Therapy; Sleep Apnea Syndromes; Sulfonamides; Treatment Outcome

2008